$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Non-polymeric sustained release delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-002/02
  • A61K-047/30
출원번호 US-0549414 (1995-10-27)
발명자 / 주소
  • Dunn Richard L.
출원인 / 주소
  • Atrix Laboratories, Inc.
대리인 / 주소
    Merchant, Gould, Smith, Edell,Welter and Schmidt
인용정보 피인용 횟수 : 192  인용 특허 : 18

초록

The invention relates to a method and composition for forming an implant in-situ within a body using non-polymeric materials, and the use of such implants as medical devices and drug delivery systems. The composition can be applied to an animal to treat periodontal disease or other tissue defect, en

대표청구항

[ What is claimed is:] [1.] A method of treating a tissue defect in an animal, comprising:(a) administering a composition to the tissue defect, the composition comprising:(i) a non-polymeric, water-insoluble material that is biodegradable; and(ii) a biocompatible, organic solvent that at least parti

이 특허에 인용된 특허 (18)

  1. Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods for producing the same.
  2. Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
  3. Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
  4. Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David P. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
  5. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
  6. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
  7. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
  8. Langer Robert S. (Somerville MA) Rosen Howard (Montara CA) Linhardt Robert J. (Iowa City IA) Leong Kam (Cambridge MA), Bioerodible polyanhydrides for controlled drug delivery.
  9. Kent John S. (Palo Alto CA), Cholesterol matrix delivery system for sustained release of macromolecules.
  10. Choi ; Nam Sok ; Heller ; Jorge, Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates).
  11. Choi Nam S. (Seoul CA KRX) Heller Jorge (Palo Alto CA), Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates).
  12. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Harkrader Ronald J. (Louisville CO) Rogers Jack A. (Fort Collins CO), Intragingival delivery systems for treatment of periodontal disease.
  13. Nash Harold A. (Harrington Park NJ) Mishell ; Jr. Daniel R. (Palos Verdes Estates CA), Intravaginal ring.
  14. Robertson Dale N. (Scotch Plains NJ) Braun John (Westbury NY), Method for making an IUD with shrinking of a medicated attachment onto a support.
  15. Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  16. Radhakrishnan Ramachandran (Fremont CA), Novel liposome composition for sustained release of steroidal drugs in lungs.
  17. Schindler Anton (Durham NC), Porous bioabsorbable polyesters.
  18. Pitt Colin G. (RTI ; P. O. Box 12194 Research Triangle Park NC 27709) Schindler Anton E. (RTI ; P. O. Box 12194 Research Triangle Park NC 27709), Sustained subdermal delivery ofdrugs using poly(e 상세보기

이 특허를 인용한 특허 (192)

  1. Allen, Douglas J.; Dekemper, Kurt D.; Ferguson, Thomas H.; Garvin, Stuart J.; Murray, Linda C.; Brooks, Norman D.; Bunnell, Charles A.; Mascarenhas, Snehlata S.; Shinkle, Sharon L.; Hendriksen, Barry, 2-methyl-thieno-benzodiazepine formulation.
  2. Allen,Douglas J.; Dekemper,Kurt D.; Ferguson,Thomas H.; Garvin,Stuart J.; Murray,Linda C.; Brooks,Norman D.; Bunnell,Charles A.; Mascarenhas,Snehlata S.; Shinkle,Sharon L.; Hendriksen,Barry A.; Tupper,David E.; Sanchez Felix,Manuel V., 2-methyl-thieno-benzodiazepine formulation.
  3. Kennedy, John P.; Jones, II, Curtis E., Agents for controlling biological fluids and methods of use thereof.
  4. Dervan, Peter B.; Briehn, Christoph A.; Renneberg, Dorte; Weyermann, Philipp; Doss, Raymond; Marques, Michael, Alternative heterocycles for DNA recognition.
  5. Slack, Frank J.; Boehm, Michelle M., Anti-aging micrornas.
  6. Kühn, Klaus-Dieter; Vogt, Sebastian; Schnabelrauch, Matthias, Antibiotic coating of implants.
  7. Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Barrier layer.
  8. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Barrier layer with underlying medical device and one or more reinforcing support structures.
  9. Zamora, Paul O.; Stern, Robert A., Bioabsorbable brachytherapy device.
  10. Guo, Hong; Chen, Jianbing; Su, Dongling; Ashton, Paul, Bioerodible sustained release drug delivery systems.
  11. Myc, Andrzej; Kryczek, Ilona; Baker, Jr., James R., Cancer vaccine compositions and methods of using the same.
  12. Conway, Anthony J.; McLeod, Patrick H.; Grinde, Sarah L.; Wiste, Jeremy M., Catheter grip and method.
  13. Conway, Anthony J.; Grinde, Sarah L., Catheter in bag without additional packaging.
  14. Day, Robert Edward; Megson, Stephen Manfred; Wood, David John, Chemical supplementation of bone.
  15. Martakos, Paul; Herweck, Steve A.; Prowse, Jocelyn; Horton, Anthony Richard; Faucher, Keith M.; Ferraro, Joseph, Coated surgical mesh.
  16. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph F.; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Coating material and medical device system including same.
  17. Krieg, Arthur M.; Vollmer, Jorg, Combination motif immune stimulatory oligonucleotides with improved activity.
  18. Kay,Robert A.; Thomas,Larry K.; Bogue,Beuford A., Composition and method for maintaining healthy mobile joints and cartilage.
  19. Kay, Robert A.; Thomas, Larry K.; Bogue, Beuford A., Composition and method for treatment of conditions having an inflammatory component.
  20. Holoshitz, Joseph; Ling, Song; Pi, Xiujun; de Almeida, Denise; Gilon, Chaim; Hoffman, Amnon, Compositions and methods for inducing an immune response.
  21. Holoshitz, Joseph; Ling, Song; Pi, Xiujun; de Almeida, Denise; Gilon, Chaim; Hoffman, Amnon, Compositions and methods for inducing an immune response.
  22. Burns Patrick J. ; Gibson John W. ; Tipton Arthur J., Compositions suitable for controlled release of the hormone GnRH and its analogs.
  23. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  24. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  25. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  26. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  27. Pappalardo, Juan Sebastian; Toniutti, Micaela; Salmaso, Stefano; Levchenko, Tatyana S.; Torchilin, Vladimir, Compounds and methods for targeted immune system delivery.
  28. Hyde, Roderick A.; Ishikawa, Muriel Y.; Wood, Jr., Lowell L., Condoms configured to facilitate release of nitric oxide.
  29. Lee-Sepsick, Kathy; Azevedo, Max S., Contrast agent generation and injection system for sonographic imaging.
  30. Lee-Sepsick, Kathy; Azevedo, Max S., Contrast agent injection system for sonographic imaging.
  31. Verity, A. Neil, Controlled delivery system.
  32. Verity, A. Neil, Controlled delivery system.
  33. Verity, A. Neil, Controlled delivery system.
  34. Verity, A. Neil, Controlled delivery system.
  35. Norton, Richard L.; Dadey, Eric, Controlled release copolymer formulation with improved release kinetics.
  36. Fraatz, Kristine; Mertin, Dirk; Heep, Iris, Controlled release system.
  37. Faucher, Keith M.; Tang, Hui; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  38. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  39. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  40. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Cured gel and method of making.
  41. Faucher, Keith M.; Conroy, Suzanne; Albergo, Theresa K.; Bienkiewicz, Joseph, Cured oil-hydrogel biomaterial compositions for controlled drug delivery.
  42. Dervan, Peter B.; Foister, Shane; Doss, Raymond; Marques, Michael A., DNA-binding polymers.
  43. Dervan,Peter B.; Foister,Shane; Doss,Raymond; Marques,Michael A., DNA-binding polymers.
  44. Dadey, Eric; Watkins, Andrew, Dehydrated hydrogel inclusion complex.
  45. Dadey, Eric; Watkins, Andrew (Drew), Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system.
  46. Hyde, Roderick A.; Ishikawa, Muriel Y.; Stordal, Leif T.; Wood, Jr., Lowell L., Devices and systems that deliver nitric oxide.
  47. Hyde, Roderick A.; Ishikawa, Muriel Y.; Stordal, Leif T.; Wood, Jr., Lowell L., Devices and systems that deliver nitric oxide.
  48. Bamdad, Cynthia C., Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer.
  49. Bamdad, Cynthia C.; Bamdad, R. Shoshana, Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer.
  50. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
  51. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
  52. Swanick, Thomas M.; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul, Fatty-acid based particles.
  53. Brodbeck Kevin J. ; Gaynor-Duarte Ann T. ; Shen Theodore Tao-Ian, Gel composition and methods.
  54. Kevin J. Brodbeck ; Ann T. Gaynor-Duarte ; Theodore Tao-Ian Shen, Gel composition and methods.
  55. Jones, Richard E.; Washco, Keith; Roskos, Kathleen V.; Maskiewicz, Richard; Trager, George, Gel delivery vehicles for anticellular proliferative agents.
  56. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Heat cured gel and method of making.
  57. Gibson, John W.; Miller, Stacey S.; Middleton, John C.; Tipton, Arthur J., High viscosity liquid controlled delivery system and medical or surgical device.
  58. John W. Gibson ; Stacey A. Sullivan ; John C. Middleton ; Arthur J. Tipton, High viscosity liquid controlled delivery system and medical or surgical device.
  59. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
  60. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steven A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
  61. Lipford, Grayson B.; Zepp, Charles M., Imidazole quinoline-based immune system modulators.
  62. Lipford, Grayson B.; Zepp, Charles M., Immune system modulators.
  63. Lipford, Grayson B.; Zepp, Charles M., Immune system modulators.
  64. Lipford, Grayson B.; Zepp, Charles M., Immune system modulators.
  65. Lipford, Grayson B.; Zepp, Charles M., Immune system modulators.
  66. Lipford, Grayson B.; Zepp, Charles M., Immune system modulators.
  67. Krieg, Arthur M.; Kline, Joel N.; Klinman, Dennis; Steinberg, Alfred D., Immunostimulatory nucleic acid molecules.
  68. Krieg, Arthur M.; Kline, Joel; Klinman, Dennis; Steinberg, Alfred D., Immunostimulatory nucleic acid molecules.
  69. Munnes, Marc; Weiss, Christian; Feldhues, Elisabeth; Schauer, Romina G.; Abraham, Albert; Eicker, Andrea; Wehlmann, Hermann, Immunostimulatory plasmids.
  70. Hall,Jan; Engman,Fredrik, Implant having attachment and hole-insert parts, and method for producing such an implant.
  71. Hall, Jan, Implant provided with attachment and hole-insert parts, and a method for producing such an implant.
  72. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Implantable barrier device.
  73. Adamis, Anthony P.; Miller, Joan W.; Gragoudas, Evangelos S.; Mescher, Mark J.; Dubé, Christopher E.; Borenstein, Jeffrey T.; Weinstein, Marcie G.; Miller, Raanan A.; Hansberry, Mitchell L., Implantable drug delivery device and use thereof.
  74. Su, Dongling; Ashton, Paul; Chen, Jianbing, In situ gelling drug delivery system.
  75. Murthy,Yerramilli V.S.N.; Suva,Robert H., Injectable compositions for the controlled delivery of pharmacologically active compound.
  76. Brodbeck Kevin J. ; Shen Theodore T., Injectable depot gel composition and method of preparing the composition.
  77. Tice Thomas R. ; Staas Jay K. ; Ferrell Teresa M., Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol.
  78. Xu, Aimin; Wang, Yu; Lam, Karen S. L., Lipocalin-2 antibodies for methods of treatment.
  79. Chern, Rey T.; Zingerman, Joel R., Liquid polymeric compositions for controlled release of bioactive substances.
  80. Dadey, Eric; Middleton, John; Norton, Richard L., Low burst polymers and methods to produce polymer.
  81. Dunn, Richard L., Low viscosity liquid polymeric delivery system.
  82. Dadey, Eric; Middleton, John; Norton, Richard L., Low-burst polymers and methods to produce polymer.
  83. Dadey, Eric; Middleton, John; Norton, Richard L., Low-burst polymers and methods to produce polymer.
  84. Dadey, Eric; Middleton, John; Norton, Richard L., Low-burst polymers and methods to produce polymer.
  85. Dadey, Eric; Middleton, John; Norton, Richard L., Low-burst polymers and methods to produce polymers.
  86. Conway, Anthony J.; Fryer, Jr., Richard D., Male external catheter with absorbent and adhesive.
  87. Contiliano, Joseph H.; Li, Yufu; Li, Zhigang, Medical fixation devices with improved torsional drive head.
  88. Contiliano, Joseph H.; Li, Yufu; Li, Zhigang, Medical fixation devices with improved torsional drive head.
  89. Corbeil, Scott E.; Labrecque, Roger; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Bromander, Edward; Henrich, Georgette, Method and apparatus for application of a fresh coating on a medical device.
  90. Coffee, Ronald Alan; Pirrie, Alastair Bruce; Davies, David Neville, Method and apparatus for manufacturing dissolvable tablets.
  91. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Method and devices for conduit occlusion.
  92. Clark,Brian Collingwood; Cross,David Michael; Gellert,Paul Richard; Kittlety,Rodney Simon, Method for determining release of a peptide from a sustained release polylactide formulation.
  93. Davis,Heather L.; Schorr,Joachim; Krieg,Arthur M., Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant.
  94. Gross, Benjamin J.; Kahne, Suzanne Walker; Swoboda, Jonathan G., Methods and compositions for detecting and modulating O-glycosylation.
  95. Gross, Benjamin; Kahne, Suzanne Walker; Swoboda, Jonathan G., Methods and compositions for detections and modulating O-glycosylation.
  96. Kahne, Suzanne Walker; Swoboda, Jonathan G.; Meredith, Timothy C.; Lee, Kyungae; Campbell, Jennifer, Methods and compounds for antimicrobial intervention.
  97. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S., Methods and devices for conduit occlusion.
  98. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S., Methods and devices for conduit occlusion.
  99. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S., Methods and devices for conduit occlusion.
  100. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S., Methods and devices for conduit occlusion.
  101. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  102. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  103. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  104. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  105. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  106. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  107. Lee-Sepsick, Kathy; Paxton, Lani L. L.; Marcus, Jeffrey A.; Williams, Stephen N., Methods and devices for conduit occlusion.
  108. Lee-Sepsick, Kathy, Methods and devices for delivering to conduit.
  109. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S.; Marcus, Jeffrey A., Methods and devices for delivery of compositions to conduits.
  110. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S.; Marcus, Jeffrey A., Methods and devices for delivery of compositions to conduits.
  111. Lee-Sepsick, Kathy; Azevedo, Max S.; Currie, Daniel S.; Marcus, Jeffrey A., Methods and devices for delivery of compositions to conduits.
  112. Lee-Sepsick, Kathy; Azevedo, Max S., Methods and devices for sonographic imaging.
  113. Lee-Sepsick, Kathy; Azevedo, Max S., Methods and devices for sonographic imaging.
  114. Hyde, Roderick A.; Ishikawa, Muriel Y.; Wood, Jr., Lowell L., Methods and systems for use of photolyzable nitric oxide donors.
  115. Hyde, Roderick A.; Ishikawa, Muriel Y.; Wood, Jr., Lowell L., Methods and systems for use of photolyzable nitric oxide donors.
  116. Weiner, George; Hartmann, Gunther, Methods for enhancing antibody-induced cell lysis and treating cancer.
  117. Bamdad, Cynthia C., Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors.
  118. Dow, Steven W.; Elmslie, Robyn E.; Schwarze, Jurgen Karl Johannes; Gelfand, Erwin W., Methods of using nucleic acid vector-lipid complexes.
  119. Glazer, Peter M.; Siedman, Michael M., Modified triple-helix forming oligonucleotides for targeted mutagenesis.
  120. Bodmeier,Roland, Multiphase system.
  121. Baker, James R.; Rathinavelu, Sivaprakash; Makidon, Paul E.; LiPuma, John J.; Nigavekar, Shraddha, Nanoemulsion therapeutic compositions and methods of using the same.
  122. Baker, Jr., James R.; Rathinavelu, Sivaprakash; Makidon, Paul E.; LiPuma, John J.; Nigavekar, Shraddha, Nanoemulsion therapeutic compositions and methods of using the same.
  123. Hyde, Roderick A.; Ishikawa, Muriel Y.; Wood, Jr., Lowell L., Nitric oxide permeable housings.
  124. Hyde, Roderick A.; Ishikawa, Muriel Y.; Stordal, Leif T.; Wood, Jr., Lowell L., Nitric oxide sensors and systems.
  125. Kabra, Bhagwati P.; Howie, Janet D., Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use.
  126. Kabra, Bhagwati P.; Howie, Janet D., Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use.
  127. Dunn Richard L., Non-polymeric sustained release delivery system.
  128. Kahne, Suzanne Walker; Lazarus, Michael Block; Gross, Benjamin J., O-GlcNAc transferase inhibitors and uses thereof.
  129. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  130. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  131. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  132. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  133. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  134. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  135. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  136. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  137. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  138. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  139. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  140. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  141. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharamaceutical dosage forms.
  142. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  143. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  144. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  145. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  146. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  147. Nonomura, Yuusuke; Ikuta, Tonami; Matsumoto, Hideki, Oral treatment/care agent.
  148. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated bioabsorbable oil film and methods for making the same.
  149. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated fatty acid films.
  150. Murthy, Yerramilli V. S. N., Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same.
  151. Murthy, Yerramilli V. S. N., Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same.
  152. Kabra, Bhagwati P., Pharmaceutical compositions for otic use.
  153. Li, Yuhua; Chien, Benjamin, Pharmaceutical compositions for sustained release delivery of peptides.
  154. Li, Yuhua; Chien, Benjamin, Pharmaceutical compositions for sustained release delivery of peptides.
  155. Murthy, Yerramilli V. S. N., Phospholipid gel compositions for drug delivery and methods of treating conditions using same.
  156. Murthy, Yerramilli V. S. N., Phospholipid gel compositions for drug delivery and methods of treating conditions using same.
  157. Murthy, Yerramilli V. S. N., Phospholipid gel compositions for drug delivery and methods of treating conditions using same.
  158. Yerramilli, Murthy V. S. N., Phospholipid gel compositions for drug delivery and methods of treating conditions using same.
  159. Branham,Keith; Chaubal,Mahesh V.; English,James P.; Hall,Donna; Zhao,Zhong, Phosphorous-containing compounds with polymeric chains, and methods of making and using the same.
  160. Branham, Keith; Chaubal, Mahesh V.; English, James P.; Hall, Donna; Zhao, Zhong, Phosphorus-containing compounds with polymeric chains, and methods of making and using the same.
  161. Branham, Keith; Chaubal, Mahesh V.; English, James P.; Hall, Donna; Zhao, Zhong, Phosphorus-containing compounds with polymeric chains, and methods of making and using the same.
  162. Johnson, Brian K.; Prud'homme, Robert K., Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use.
  163. Glazer, Peter M., Pseudocomplementary oligonucleotides for targeted gene therapy.
  164. Slack, Frank J.; Johnson, Steven M.; Grosshans, Helge, Regulation of oncogenes by microRNAs.
  165. Slack, Frank J.; Johnson, Steven M.; Grosshans, Helge; Weidhaas, Joanne Barnes, Regulation of oncogenes by microRNAs.
  166. Tam, Wai Leong; Weinberg, Robert A., Selective targeting of cancer stem cells.
  167. Conway, Anthony J.; Grinde, Sarah L., Sheath for securing urinary catheter.
  168. Conway, Anthony J.; Fryer, Jr., Richard D., Silicone rubber male external catheter with absorbent and adhesive.
  169. Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Stand-alone film and methods for making the same.
  170. Maskiewicz, Richard, Sublimable sustained release delivery system and method of making same.
  171. Maskiewicz, Richard, Sublimable sustained release delivery system and method of making same.
  172. Hyde, Roderick A.; Ishikawa, Muriel Y.; Stordal, Leif T.; Wood, Jr., Lowell L., Substrates for nitric oxide releasing devices.
  173. Hyde, Roderick A.; Ishikawa, Muriel Y.; Stordal, Leif T.; Wood, Jr., Lowell L., Substrates for nitric oxide releasing devices.
  174. Margaron, Philippe Maria Clotaire; Dadey, Eric; Lindemann, Christopher M.; Li, Ruihong, Sustained delivery formulations of rapamycin compounds.
  175. Kelnar, Kevin; Brown, David, Synthetic mimics of miR-34.
  176. Kelnar, Kevin; Brown, David, Synthetic mimics of miR-34.
  177. Hyde, Roderick A.; Ishikawa, Muriel Y.; Wood, Jr., Lowell L., Systems and devices that utilize photolyzable nitric oxide donors.
  178. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Tissue separating device with reinforced support for anchoring mechanisms.
  179. Swanick, Thomas M.; Bienkiewicz, Joe; Ferraro, Joseph; Martakos, Paul; Faucher, Keith M.; Dale, Alicia, Tissue-separating fatty acid adhesion barrier.
  180. Yum, Su II; Kwon, Sung Yun; Song, Xiaoping; Brown, James E., Transdermal delivery systems.
  181. Ameer,Guillermo A.; Crumpler,Eric T.; Langer,Robert S., Transdermal thermal polymerization.
  182. Moss, Jonathan; Singleton, Patrick A., Treatment with opioid antagonists and mTOR inhibitors.
  183. Moss, Jonathan; Singleton, Patrick A., Treatment with opioid antagonists and mTOR inhibitors.
  184. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; Swanick, Thomas M., UV cured gel and method of making.
  185. Xu, Aimin; Wang, Yu; Lam, Karen Siu Ling, Use of lipocalin-2 as a diagnostic marker and therapeutic target.
  186. Kropf Christian,DEX ; Foerster Thomas,DEX ; Fabry Bernd,DEX ; Hollenbrock Martina,DEX, Use of nanoscale sterols and sterol esters.
  187. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists.
  188. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists.
  189. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N., Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  190. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  191. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
  192. Moss, Jonathan; Lingen, Mark; Singleton, Patrick A.; Garcia, Joe G. N.; Yuan, Chun-Su, Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로